Human plasma kallikrein releases neutrophil elastase during blood coagulation.
Open Access
- 1 November 1983
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 72 (5) , 1672-1677
- https://doi.org/10.1172/jci111126
Abstract
Elastase is released from human neutrophils during the early events of blood coagulation. Human plasma kallikrein has been shown to stimulate neutrophil chemotaxis, aggregation, and oxygen consumption. Therefore, the ability of kallikrein to release neutrophil elastase was investigated. Neutrophils were isolated by dextran sedimentation, and elastase release was measured by both an enzyme-linked immunosorbent assay, and an enzymatic assay using t-butoxy-carbonyl-Ala-Ala-Pro-Val-amino methyl coumarin as the substrate. Kallikrein, 0.1-1.0 U/ml, (0.045-0.45 microM), was incubated with neutrophils that were preincubated with cytochalasin B (5 micrograms/ml). The release of elastase was found to be proportional to the kallikrein concentration. Kallikrein released a maximum of 34% of the total elastase content, as measured by solubilizing the neutrophils in the nonionic detergent Triton X-100. A series of experiments was carried out to determine if kallikrein was a major enzyme involved in neutrophil elastase release during blood coagulation. When 10 million neutrophils were incubated in 1 ml of normal plasma in the presence of 30 mM CaCl2 for 90 min, 2.75 micrograms of elastase was released. In contrast, neutrophils incubated in prekallikrein-deficient or Factor XII-deficient plasma released less than half of the elastase, as compared with normal plasma. The addition of purified prekallikrein to prekallikrein-deficient plasma restored neutrophil elastase release to normal levels. Moreover, release of elastase was enhanced in plasma deficient in C1-inhibitor, the major plasma inhibitor of kallikrein. This release was not dependent upon further steps in the coagulation pathway, or on C5a, since levels of elastase, released in Factor XI- or C5-deficient plasma, were similar to that in normal plasma, and an antibody to C5 failed to inhibit elastase release. These data suggest that kallikrein may be a major enzyme responsible for the release of elastase during blood coagulation.This publication has 22 references indexed in Scilit:
- Purified human plasma kallikrein aggregates human blood neutrophils.Journal of Clinical Investigation, 1982
- Leukocyte Elastase Release during Blood CoagulationJournal of Clinical Investigation, 1982
- Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit.The Journal of Experimental Medicine, 1981
- Activation of the classical pathway of complement by Hageman factor fragment.The Journal of Experimental Medicine, 1981
- Solid-phase immunoassay of dog neutrophil elastaseAnalytical Biochemistry, 1980
- Sensitive substrates for human leukocyte and porcine pancreatic elastase: A study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteasesAnalytical Biochemistry, 1979
- Human leukocyte granule elastase: rapid isolation and characterizationBiochemistry, 1976
- Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.Journal of Clinical Investigation, 1974
- A PREALBUMIN ACTIVATOR OF PREKALLIKREINThe Journal of Experimental Medicine, 1972
- MECHANISMS OF ACTIVATION OF C'1 ESTERASE IN HEREDITARY ANGIONEUROTIC EDEMA PLASMA IN VITROThe Journal of Experimental Medicine, 1968